Physician profile
Nicholas Moore
NPI 1770978645
$2,101.81
in general payments reported to CMS, 2019-2025
20 companies · $321 in 2025
The $321 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $778 · 2020: $136 · 2021: $91.59 · 2022: $112 · 2023: $262 · 2024: $401 · 2025: $321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $984.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $984.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $955.34 | 2019-2025 | Clareon, Ngenuity, Lensx |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $200.69 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $179.41 | 2023-2024 | Tecnis Iol, Tecnis Iol |
| Regeneron Healthcare Solutions, INC. | $117.79 | 2019 | |
| Spark Therapeutics, INC. | $100.30 | 2019 | |
| Novartis Pharmaceuticals Corporation | $88.74 | 2019 | |
| Allergan, INC. | $85.66 | 2020-2022 | |
| Abbvie INC. | $83.21 | 2022-2025 | |
| Bausch & Lomb Americas INC. | $48.85 | 2023-2025 | Vyzulta, Xiidra, Miebo |
| Aerie Pharmaceuticals, INC. | $37.21 | 2020 | |
| Sun Pharmaceutical Industries INC. | $36.49 | 2020-2021 | |
| Dompe US, INC. | $35.05 | 2025 | Oxervate |
| Rxsight INC | $22.02 | 2022 | |
| Oyster Point Pharma, INC. | $19.70 | 2024 | Tyrvaya |
| Astellas Pharma US INC | $18.26 | 2024 | Izervay |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Omeros Corporation | $17.91 | 2019 | |
| Lkc Technologies, INC. | $16.97 | 2025 | |
| Sight Sciences, INC. | $13.68 | 2024 | Omni Surgical System |
| New World Medical,INC. | $13.27 | 2022 | |
| Genentech USA, INC. | $11.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.